Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$2.15 - $5.68 $317,015 - $837,510
-147,449 Reduced 74.68%
50,000 $107,000
Q2 2023

Aug 14, 2023

SELL
$5.6 - $9.66 $763,767 - $1.32 Million
-136,387 Reduced 40.85%
197,449 $1.11 Million
Q1 2023

May 15, 2023

BUY
$4.81 - $10.95 $1.61 Million - $3.66 Million
333,836 New
333,836 $2.01 Million

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $6.22M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.